Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertension

about

Lipid-lowering efficacy of rosuvastatin Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.Pathogenesis and management of the diabetogenic effect of statins: a role for adiponectin and coenzyme Q10?

P2860

Q24187891-D7634514-68BA-42B1-827E-027B76C93A20 Q38208727-6658F16D-FD3A-47EA-ADE2-CB03377E3F70 Q38268344-2BB0D9CB-67F3-452C-94E1-54C97B1DB7BE

P2860

Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertension

Item

http://www.wikidata.org/entity/Q36837587

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Rosuvastatin does not affect f ...... mild to moderate hypertension

@en

type

Item

label

Rosuvastatin does not affect f ...... mild to moderate hypertension

@en

prefLabel

Rosuvastatin does not affect f ...... mild to moderate hypertension

@en

P1476

Rosuvastatin does not affect f ...... mild to moderate hypertension

@en

P2093

Jong Shin Woo

http://www.w3.org/2001/XMLSchema#string

Myong Joo Hong

http://www.w3.org/2001/XMLSchema#string

Sun Ho Hwang

http://www.w3.org/2001/XMLSchema#string

Wan Kim

http://www.w3.org/2001/XMLSchema#string

Weon Kim

http://www.w3.org/2001/XMLSchema#string

Won Yu Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.

Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia.

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study.

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.

Simvastatin improves flow-mediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients.

Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome.

P304

31-37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4068/CMJ.2013.49.1.31

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236913093

http://www.w3.org/2001/XMLSchema#string

P698

23678475

http://www.w3.org/2001/XMLSchema#string

P932

3651984

http://www.w3.org/2001/XMLSchema#string

Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertension

about

P2860

P2860

Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertension

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932